Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications
- 作者Teh-Ia Huo; Han-Chieh Lin; Jaw-Ching Wu; Ming-Chih Hou; Fa-Yauh Lee; Pui-Ching Lee; Full-Young Chang; Shou-Dong Lee
- 卷第20卷
- 期第2期
- 印刷ISSN0902-0063
- 电子ISSN1399-0012
- 文件大小175.97KB
- 发表时间2006
- DOI10.1111/j.1399-0012.2005.00463.x
- 页码188-194
Organ acceptance and rejectionMark D Pescovitz · 1992
Drugs for the hypersensitized patientPescovitz, Mark D · Current Opinion in Organ Transplantation · 2005
Immunosuppressive therapy and post-transplantation diarrheaMark D Pescovitz; Mercidita T Navarro · 2001
Maribavir: a new oral anti-cytomegalovirus drugPescovitz, Mark D · Future Virology · 2008
Neurologic complications of pediatric liver transplantationGarg, Bhuwan P.; Walsh, Laurence E.; Pescovitz, Mark D.; Patel, Hema; Chong, Sonny; Filo, Ronald S.; Fitzgerald, Joseph · 1993
Valganciclovir: what is the status in solid organ transplantation?Pescovitz, Mark D · Future Virology · 2006
Daclizumab: humanized monoclonal antibody to the interleukin-2 receptorPescovitz, Mark D · Expert Review of Clinical Immunology · 2005
Use of antibody induction in pediatric renal transplantationPescovitz, Mark D · Current Opinion in Organ Transplantation · 2008